These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9029233)

  • 1. Eglin-c prevents monocrotaline-induced ventilatory dysfunction.
    Lai YL; Zhou KR
    J Appl Physiol (1985); 1997 Jan; 82(1):324-8. PubMed ID: 9029233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Difluoromethylornithine attenuates monocrotaline-induced airway/lung dysfunction.
    Zhou KR; Lai YL
    J Appl Physiol (1985); 1992 May; 72(5):1914-21. PubMed ID: 1601800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension.
    Zhou KR; Lai YL
    J Appl Physiol (1985); 1993 Dec; 75(6):2781-8. PubMed ID: 7510280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of porcine pancreatic elastase-induced emphysema by eglin-c.
    Lai YL; Diamond L
    Exp Lung Res; 1990; 16(5):547-57. PubMed ID: 2226359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL; Olson JW; Gillespie MN
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elastase in hyperpnea-induced guinea pig airway constriction.
    Lai YL; Lin YJ
    Eur J Pharmacol; 1998 Oct; 359(2-3):171-6. PubMed ID: 9832388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.
    Colice GL; Hill N; Lee YJ; Du H; Klinger J; Leiter JC; Ou LC
    J Appl Physiol (1985); 1997 Jul; 83(1):25-31. PubMed ID: 9216940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arginine-related responses to pressure and vasoactive agents in monocrotaline-treated rat pulmonary arteries.
    Madden JA; Keller PA; Choy JS; Alvarez TA; Hacker AD
    J Appl Physiol (1985); 1995 Aug; 79(2):589-93. PubMed ID: 7592222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
    Nakazawa H; Hori M; Ozaki H; Karaki H
    Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R; Zeballos GA; Tun H; Gewitz MH
    Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
    Mathew R; Gloster ES; Sundararajan T; Thompson CI; Zeballos GA; Gewitz MH
    J Appl Physiol (1985); 1997 May; 82(5):1493-8. PubMed ID: 9134898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats.
    Yang DL; Zhang HG; Xu YL; Gao YH; Yang XJ; Hao XQ; Li XH
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):150-5. PubMed ID: 19566840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of elastase inhibitor on pulmonary hypertension induced by monocrotaline].
    Fu LJ; Zhou AQ; Shen J; Zhao W; Li F
    Zhonghua Er Ke Za Zhi; 2004 May; 42(5):375-8. PubMed ID: 15189699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension.
    Chen MJ; Chiang LY; Lai YL
    Toxicol Appl Pharmacol; 2001 Mar; 171(3):165-73. PubMed ID: 11243916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
    Voelkel NF; Tuder RM; Bridges J; Arend WP
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of pulmonary vascular resistance by improved right heart catheter in rat].
    Yuan P; Wu WH; Liu D; Zhang R; Jing ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):901-4. PubMed ID: 22321272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.